Strategic Insights Lead, Oncology Portfolio

AbbVie Inc.

South San Francisco (CA)

On-site

USD 150,000 - 190,000

Full time

2 days ago

Be an early applicant

Application generator

Don’t send a generic resume — generate a resume and cover letter tailored to this exact role.

Get past ATS filters

Job summary

AbbVie Inc. is seeking an Associate Director, Business Insights to partner with Oncology/SMAO and Neuroscience/SSU leadership.

You will translate complex questions into data-driven analyses, deliver portfolio-level insights, and influence senior decision-making across site strategy, study design, and resourcing. You will own analytics products, mentor junior staff, and ensure consistency across therapeutic areas.

Qualifications

Bachelor’s degree required; Master’s preferred
10+ years of experience in business analytics, strategy, or related client-facing analytical role
Pharma/biotech/healthcare experience with senior stakeholder interaction
Strong ability to translate ambiguous questions into structured analyses
Excellent written and verbal communication for executive audiences
Proficiency with SQL, Power BI, and Excel

Responsibilities

Strategic Partnership & Stakeholder Engagement: Serve as the primary SABI point of contact and trusted advisor to Oncology/SMAO Sr. Directors and CSL leadership, proactively identifying where data and analytics can resolve ambiguity in portfolio-level decisions.
End-to-End Insight Delivery: Lead delivery of portfolio-level insights — from hypothesis generation and data identification through analysis, insight generation, and recommendations — following SABI’s hypothesis-driven problem-solving approach.
Analytical Product Ownership: Own and evolve key analytical products for Oncology/SMAO (e.g., site ID and allocation models, country/site performance benchmarking, enrollment scenario planning, operational flagging views), ensuring they remain decision-relevant as portfolio priorities shift.
Cross-TA Support — Neuroscience/SSU: Provide analytical and decision-support coverage to Neuroscience/SSU stakeholders, extending proven Oncology approaches where transferable and adapting them to Neuroscience/SSU-specific needs.
Business Need Translation: Partner with Sr. Directors and CSL leadership across Oncology/SMAO and Neuroscience/SSU to translate emerging business needs into scoped, actionable analytical workstreams.
Executive Communication: Influence Sr. Directors/VP-level decisions, tailoring communication to executive audiences.
Risk & Gap Identification: Identify and elevate structural gaps or unaddressed risks within the Oncology/SMAO and Neuroscience/SSU portfolios that are not yet visible to leadership, bringing an independent analytical lens to surface them.
Cross-Functional Collaboration: Collaborate with SABI’s other TA-aligned leads and adjacent CAP functions to ensure consistency and reuse of analytical approaches across therapeutic areas.
CDO-Wide Initiatives: Provide analytical and strategic support for priority CDO-wide initiatives, partnering across functions and applying SABI capabilities beyond assigned therapeutic areas to advance enterprise objectives.
Team Capability Development: Provide project-based coaching and mentorship to junior team members and rotational analysts supporting Oncology/SMAO and Neuroscience/SSU work, while maintaining accountability for the quality and analytical rigor of assigned outputs.
Portfolio Stewardship: Maintain a portfolio-first, objective, and long-term view of stakeholder needs across both therapeutic areas, balancing responsiveness to Sr. Director requests with SABI’s focus on high-impact, analytically complex work.